WVE - Wave Life Sciences GAAP EPS of -$0.27 misses by $0.23 revenue of $12.93M misses by $25.67M
2023-05-03 07:55:34 ET
- Wave Life Sciences press release ( NASDAQ: WVE ): Q1 GAAP EPS of -$0.27 misses by $0.23 .
- Revenue of $12.93M (+638.9% Y/Y) misses by $25.67M .
- As of March 31, 2023, Wave had $207.6 million in cash and cash equivalents, as compared to $88.5 million as of December 31, 2022.
- The company expects that its current cash and cash equivalents will be sufficient to fund operations into 2025.
For further details see:
Wave Life Sciences GAAP EPS of -$0.27 misses by $0.23, revenue of $12.93M misses by $25.67M